Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00350363 · ClinicalTrials.gov registry record · Phase 4
One Hour Preoperative Gatifloxacin
A Phase 4 study of Ophthalmic Surgery, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00350363 is a Phase 4 study of Ophthalmic Surgery that has completed, run by Stanford University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00350363, a Phase 4 study of Ophthalmic Surgery, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of 1 day versus 1 hour application of topical Zymar.
Conditions Studied
Interventions
- DRUG Zymar
Study Locations (1)
California
- Stanford - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00350363
The ClinicalTrials.gov registry entry for NCT00350363 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ophthalmic Surgery appearing as the primary indexed condition, and to 1 intervention - of which Zymar is the first listed.
NCT00350363 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00350363 about?
NCT00350363 is a clinical study titled "One Hour Preoperative Gatifloxacin". Comparison of 1 day versus 1 hour application of topical Zymar.
What is the current status of trial NCT00350363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-01. Estimated completion is 2010-12.
What conditions does trial NCT00350363 study?
This clinical trial studies the following conditions: Ophthalmic Surgery.
What interventions are being tested in trial NCT00350363?
The interventions under investigation include: Zymar (DRUG).
Who is sponsoring clinical trial NCT00350363?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00350363 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.